Frontiers in Aging Neuroscience (May 2022)

Investigating the Association Between Polygenic Risk Scores for Alzheimer’s Disease With Cognitive Performance and Intrinsic Functional Connectivity in Healthy Adults

  • Aliaa Ibnidris,
  • Aliaa Ibnidris,
  • Fabian Fußer,
  • Fabian Fußer,
  • Thorsten M. Kranz,
  • David Prvulovic,
  • Andreas Reif,
  • Johannes Pantel,
  • Emiliano Albanese,
  • Tarik Karakaya,
  • Silke Matura

DOI
https://doi.org/10.3389/fnagi.2022.837284
Journal volume & issue
Vol. 14

Abstract

Read online

BackgroundAlzheimer’s disease (AD) pathology is present many years before the onset of clinical symptoms. AD dementia cannot be treated. Timely and early detection of people at risk of developing AD is key for primary and secondary prevention. Moreover, understanding the underlying pathology that is present in the earliest stages of AD, and the genetic predisposition to that might contribute to the development of targeted disease-modifying treatments.ObjectivesIn this study, we aimed to explore whether genetic disposition to AD in asymptomatic individuals is associated with altered intrinsic functional connectivity as well as cognitive performance on neuropsychological tests.MethodsWe examined 136 cognitively healthy adults (old group: mean age = 69.32, SD = 4.23; young group: mean age = 31.34, SD = 13.12). All participants had undergone resting-state functional magnetic resonance imagining (fMRI), DNA genotyping to ascertain polygenic risk scores (PRS), and neuropsychological testing for global cognition, working memory, verbal fluency, and executive functions.ResultsTwo-step hierarchical regression analysis revealed that higher PRS was significantly associated with lower scores in working memory tasks [Letter Number Span: ΔR2 = 0.077 (p < 0.05); Spatial Span: ΔR2 = 0.072 (p < 0.05)] in older adults (>60 years). PRS did not show significant modulations of the intrinsic functional connectivity of the posterior cingulate cortex (PCC) with other regions of interest in the brain that are affected in AD.ConclusionAllele polymorphisms may modify the effect of other AD risk factors. This potential modulation warrants further investigations, particularly in cognitively healthy adults.

Keywords